CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Open-label Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER) Tablets in GNE Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy (HIBM)) Patients With Severe Ambulatory Impairment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02731690
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:00.278145+00:00
Published At: 2019-02-19T00:00:00+00:00
Record Updated At: 2019-02-19
Results Posted At: 2019-02-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hereditary Inclusion Body Myopathy", "Distal Myopathy With Rimmed Vacuoles", "Distal Myopathy, Nonaka Type", "GNE Myopathy", "Quadriceps Sparing Myopathy", "Inclusion Body Myopathy 2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-02-19"
protocolSection.identificationModule.nctId: "NCT02731690"
protocolSection.identificationModule.officialTitle: "A Phase 2 Open-label Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER) Tablets in GNE Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy (HIBM)) Patients With Severe Ambulatory Impairment"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-02-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.